AVITA Medical Inc (ASX:AVH)
A$ 2.51 -0.18 (-6.69%) Market Cap: 326.18 Mil Enterprise Value: 312.88 Mil PE Ratio: 0 PB Ratio: 9.47 GF Score: 72/100

AVITA Medical Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 07:15PM GMT
Release Date Price: A$4.56 (+12.59%)
Farhan Khan JPMorgan Chase;Co.;Analyst

&-

Good morning and welcome to the last day of the conference. My name is Farhan Khan, I'm an associate at JPMorgan. It's my great pleasure today to introduce Jim Corbett, CEO of AVITA Medical. Please join me in welcoming Jim.

Jim Corbett AVITA Medical
Inc. - CEO

Thank you Farhan, and thanks to all of you who are here and who are listening. I'm excited to share with you the AVITA story. We've really evolved in the last year and really moved into unquestionably a accelerated growth period of the company's life. We have a very strong seasoned management team with strong experience in the field and in health care and in growing health care businesses rapidly.

Let me give you a big picture of what AVITA is for those who might be listening for the first time, we're a commercial stage company. So we are actively building our business. We are not in the research mode. We have approved indications for our technology, which is called resell, which I'll describe in some detail in a moment. But the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot